Global CGRP Monoclonal Antibodies Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
The global CGRP Monoclonal Antibodies market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LPI (LP Information)' newest research report, the “CGRP Monoclonal Antibodies Industry Forecast” looks at past sales and reviews total world CGRP Monoclonal Antibodies sales in 2022, providing a comprehensive analysis by region and market sector of projected CGRP Monoclonal Antibodies sales for 2023 through 2029. With CGRP Monoclonal Antibodies sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world CGRP Monoclonal Antibodies industry.
This Insight Report provides a comprehensive analysis of the global CGRP Monoclonal Antibodies landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on CGRP Monoclonal Antibodies portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global CGRP Monoclonal Antibodies market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for CGRP Monoclonal Antibodies and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global CGRP Monoclonal Antibodies.
United States market for CGRP Monoclonal Antibodies is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for CGRP Monoclonal Antibodies is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for CGRP Monoclonal Antibodies is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key CGRP Monoclonal Antibodies players cover Lundbeck, Alder Therapeutics, Teva, Pfizer Inc., Lilly Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of CGRP Monoclonal Antibodies market by product type, application, key players and key regions and countries.
Segmentation by Type:
The global CGRP Monoclonal Antibodies market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LPI (LP Information)' newest research report, the “CGRP Monoclonal Antibodies Industry Forecast” looks at past sales and reviews total world CGRP Monoclonal Antibodies sales in 2022, providing a comprehensive analysis by region and market sector of projected CGRP Monoclonal Antibodies sales for 2023 through 2029. With CGRP Monoclonal Antibodies sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world CGRP Monoclonal Antibodies industry.
This Insight Report provides a comprehensive analysis of the global CGRP Monoclonal Antibodies landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on CGRP Monoclonal Antibodies portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global CGRP Monoclonal Antibodies market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for CGRP Monoclonal Antibodies and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global CGRP Monoclonal Antibodies.
United States market for CGRP Monoclonal Antibodies is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for CGRP Monoclonal Antibodies is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for CGRP Monoclonal Antibodies is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key CGRP Monoclonal Antibodies players cover Lundbeck, Alder Therapeutics, Teva, Pfizer Inc., Lilly Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of CGRP Monoclonal Antibodies market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Eptinezumab
- Fremanezumab
- Galcanezumab
- Erenumab
- Hospital
- Specialty Clinic
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Eptinezumab
- Fremanezumab
- Galcanezumab
- Erenumab
- Hospital
- Specialty Clinic
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Lundbeck
- Alder Therapeutics
- Teva
- Pfizer Inc.
- Lilly Inc.
- Daiichi Sankyo Co., Ltd.
- Amgen Inc.
- Novartis International AG
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global CGRP Monoclonal Antibodies Market Size 2019-2030
2.1.2 CGRP Monoclonal Antibodies Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for CGRP Monoclonal Antibodies by Country/Region, 2019, 2023 & 2030
2.2 CGRP Monoclonal Antibodies Segment by Type
2.2.1 Eptinezumab
2.2.2 Fremanezumab
2.2.3 Galcanezumab
2.2.4 Erenumab
2.3 CGRP Monoclonal Antibodies Market Size by Type
2.3.1 CGRP Monoclonal Antibodies Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global CGRP Monoclonal Antibodies Market Size Market Share by Type (2019-2024)
2.4 CGRP Monoclonal Antibodies Segment by Application
2.4.1 Hospital
2.4.2 Specialty Clinic
2.4.3 Others
2.5 CGRP Monoclonal Antibodies Market Size by Application
2.5.1 CGRP Monoclonal Antibodies Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global CGRP Monoclonal Antibodies Market Size Market Share by Application (2019-2024)
3 CGRP MONOCLONAL ANTIBODIES MARKET SIZE BY PLAYER
3.1 CGRP Monoclonal Antibodies Market Size Market Share by Player
3.1.1 Global CGRP Monoclonal Antibodies Revenue by Player (2019-2024)
3.1.2 Global CGRP Monoclonal Antibodies Revenue Market Share by Player (2019-2024)
3.2 Global CGRP Monoclonal Antibodies Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CGRP MONOCLONAL ANTIBODIES BY REGION
4.1 CGRP Monoclonal Antibodies Market Size by Region (2019-2024)
4.2 Global CGRP Monoclonal Antibodies Annual Revenue by Country/Region (2019-2024)
4.3 Americas CGRP Monoclonal Antibodies Market Size Growth (2019-2024)
4.4 APAC CGRP Monoclonal Antibodies Market Size Growth (2019-2024)
4.5 Europe CGRP Monoclonal Antibodies Market Size Growth (2019-2024)
4.6 Middle East & Africa CGRP Monoclonal Antibodies Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas CGRP Monoclonal Antibodies Market Size by Country (2019-2024)
5.2 Americas CGRP Monoclonal Antibodies Market Size by Type (2019-2024)
5.3 Americas CGRP Monoclonal Antibodies Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC CGRP Monoclonal Antibodies Market Size by Region (2019-2024)
6.2 APAC CGRP Monoclonal Antibodies Market Size by Type (2019-2024)
6.3 APAC CGRP Monoclonal Antibodies Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe CGRP Monoclonal Antibodies Market Size by Country (2019-2024)
7.2 Europe CGRP Monoclonal Antibodies Market Size by Type (2019-2024)
7.3 Europe CGRP Monoclonal Antibodies Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa CGRP Monoclonal Antibodies by Region (2019-2024)
8.2 Middle East & Africa CGRP Monoclonal Antibodies Market Size by Type (2019-2024)
8.3 Middle East & Africa CGRP Monoclonal Antibodies Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CGRP MONOCLONAL ANTIBODIES MARKET FORECAST
10.1 Global CGRP Monoclonal Antibodies Forecast by Region (2025-2030)
10.1.1 Global CGRP Monoclonal Antibodies Forecast by Region (2025-2030)
10.1.2 Americas CGRP Monoclonal Antibodies Forecast
10.1.3 APAC CGRP Monoclonal Antibodies Forecast
10.1.4 Europe CGRP Monoclonal Antibodies Forecast
10.1.5 Middle East & Africa CGRP Monoclonal Antibodies Forecast
10.2 Americas CGRP Monoclonal Antibodies Forecast by Country (2025-2030)
10.2.1 United States Market CGRP Monoclonal Antibodies Forecast
10.2.2 Canada Market CGRP Monoclonal Antibodies Forecast
10.2.3 Mexico Market CGRP Monoclonal Antibodies Forecast
10.2.4 Brazil Market CGRP Monoclonal Antibodies Forecast
10.3 APAC CGRP Monoclonal Antibodies Forecast by Region (2025-2030)
10.3.1 China CGRP Monoclonal Antibodies Market Forecast
10.3.2 Japan Market CGRP Monoclonal Antibodies Forecast
10.3.3 Korea Market CGRP Monoclonal Antibodies Forecast
10.3.4 Southeast Asia Market CGRP Monoclonal Antibodies Forecast
10.3.5 India Market CGRP Monoclonal Antibodies Forecast
10.3.6 Australia Market CGRP Monoclonal Antibodies Forecast
10.4 Europe CGRP Monoclonal Antibodies Forecast by Country (2025-2030)
10.4.1 Germany Market CGRP Monoclonal Antibodies Forecast
10.4.2 France Market CGRP Monoclonal Antibodies Forecast
10.4.3 UK Market CGRP Monoclonal Antibodies Forecast
10.4.4 Italy Market CGRP Monoclonal Antibodies Forecast
10.4.5 Russia Market CGRP Monoclonal Antibodies Forecast
10.5 Middle East & Africa CGRP Monoclonal Antibodies Forecast by Region (2025-2030)
10.5.1 Egypt Market CGRP Monoclonal Antibodies Forecast
10.5.2 South Africa Market CGRP Monoclonal Antibodies Forecast
10.5.3 Israel Market CGRP Monoclonal Antibodies Forecast
10.5.4 Turkey Market CGRP Monoclonal Antibodies Forecast
10.6 Global CGRP Monoclonal Antibodies Forecast by Type (2025-2030)
10.7 Global CGRP Monoclonal Antibodies Forecast by Application (2025-2030)
10.7.1 GCC Countries Market CGRP Monoclonal Antibodies Forecast
11 KEY PLAYERS ANALYSIS
11.1 Lundbeck
11.1.1 Lundbeck Company Information
11.1.2 Lundbeck CGRP Monoclonal Antibodies Product Offered
11.1.3 Lundbeck CGRP Monoclonal Antibodies Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Lundbeck Main Business Overview
11.1.5 Lundbeck Latest Developments
11.2 Alder Therapeutics
11.2.1 Alder Therapeutics Company Information
11.2.2 Alder Therapeutics CGRP Monoclonal Antibodies Product Offered
11.2.3 Alder Therapeutics CGRP Monoclonal Antibodies Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Alder Therapeutics Main Business Overview
11.2.5 Alder Therapeutics Latest Developments
11.3 Teva
11.3.1 Teva Company Information
11.3.2 Teva CGRP Monoclonal Antibodies Product Offered
11.3.3 Teva CGRP Monoclonal Antibodies Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Teva Main Business Overview
11.3.5 Teva Latest Developments
11.4 Pfizer Inc.
11.4.1 Pfizer Inc. Company Information
11.4.2 Pfizer Inc. CGRP Monoclonal Antibodies Product Offered
11.4.3 Pfizer Inc. CGRP Monoclonal Antibodies Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Pfizer Inc. Main Business Overview
11.4.5 Pfizer Inc. Latest Developments
11.5 Lilly Inc.
11.5.1 Lilly Inc. Company Information
11.5.2 Lilly Inc. CGRP Monoclonal Antibodies Product Offered
11.5.3 Lilly Inc. CGRP Monoclonal Antibodies Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Lilly Inc. Main Business Overview
11.5.5 Lilly Inc. Latest Developments
11.6 Daiichi Sankyo Co., Ltd.
11.6.1 Daiichi Sankyo Co., Ltd. Company Information
11.6.2 Daiichi Sankyo Co., Ltd. CGRP Monoclonal Antibodies Product Offered
11.6.3 Daiichi Sankyo Co., Ltd. CGRP Monoclonal Antibodies Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Daiichi Sankyo Co., Ltd. Main Business Overview
11.6.5 Daiichi Sankyo Co., Ltd. Latest Developments
11.7 Amgen Inc.
11.7.1 Amgen Inc. Company Information
11.7.2 Amgen Inc. CGRP Monoclonal Antibodies Product Offered
11.7.3 Amgen Inc. CGRP Monoclonal Antibodies Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Amgen Inc. Main Business Overview
11.7.5 Amgen Inc. Latest Developments
11.8 Novartis International AG
11.8.1 Novartis International AG Company Information
11.8.2 Novartis International AG CGRP Monoclonal Antibodies Product Offered
11.8.3 Novartis International AG CGRP Monoclonal Antibodies Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Novartis International AG Main Business Overview
11.8.5 Novartis International AG Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. CGRP Monoclonal Antibodies Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. CGRP Monoclonal Antibodies Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Eptinezumab
Table 4. Major Players ofFremanezumab
Table 5. Major Players of Galcanezumab
Table 6. Major Players of Erenumab
Table 7. CGRP Monoclonal Antibodies Market Size CAGR byType (2019 VS 2023 VS 2030) & ($ millions)
Table 8. Global CGRP Monoclonal Antibodies Market Size byType (2019-2024) & ($ millions)
Table 9. Global CGRP Monoclonal Antibodies Market Size Market Share byType (2019-2024)
Table 10. CGRP Monoclonal Antibodies Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 11. Global CGRP Monoclonal Antibodies Market Size by Application (2019-2024) & ($ millions)
Table 12. Global CGRP Monoclonal Antibodies Market Size Market Share by Application (2019-2024)
Table 13. Global CGRP Monoclonal Antibodies Revenue by Player (2019-2024) & ($ millions)
Table 14. Global CGRP Monoclonal Antibodies Revenue Market Share by Player (2019-2024)
Table 15. CGRP Monoclonal Antibodies Key Players Head office and Products Offered
Table 16. CGRP Monoclonal Antibodies Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global CGRP Monoclonal Antibodies Market Size by Region (2019-2024) & ($ millions)
Table 20. Global CGRP Monoclonal Antibodies Market Size Market Share by Region (2019-2024)
Table 21. Global CGRP Monoclonal Antibodies Revenue by Country/Region (2019-2024) & ($ millions)
Table 22. Global CGRP Monoclonal Antibodies Revenue Market Share by Country/Region (2019-2024)
Table 23. Americas CGRP Monoclonal Antibodies Market Size by Country (2019-2024) & ($ millions)
Table 24. Americas CGRP Monoclonal Antibodies Market Size Market Share by Country (2019-2024)
Table 25. Americas CGRP Monoclonal Antibodies Market Size byType (2019-2024) & ($ millions)
Table 26. Americas CGRP Monoclonal Antibodies Market Size Market Share byType (2019-2024)
Table 27. Americas CGRP Monoclonal Antibodies Market Size by Application (2019-2024) & ($ millions)
Table 28. Americas CGRP Monoclonal Antibodies Market Size Market Share by Application (2019-2024)
Table 29. APAC CGRP Monoclonal Antibodies Market Size by Region (2019-2024) & ($ millions)
Table 30. APAC CGRP Monoclonal Antibodies Market Size Market Share by Region (2019-2024)
Table 31. APAC CGRP Monoclonal Antibodies Market Size byType (2019-2024) & ($ millions)
Table 32. APAC CGRP Monoclonal Antibodies Market Size by Application (2019-2024) & ($ millions)
Table 33. Europe CGRP Monoclonal Antibodies Market Size by Country (2019-2024) & ($ millions)
Table 34. Europe CGRP Monoclonal Antibodies Market Size Market Share by Country (2019-2024)
Table 35. Europe CGRP Monoclonal Antibodies Market Size byType (2019-2024) & ($ millions)
Table 36. Europe CGRP Monoclonal Antibodies Market Size by Application (2019-2024) & ($ millions)
Table 37. Middle East & Africa CGRP Monoclonal Antibodies Market Size by Region (2019-2024) & ($ millions)
Table 38. Middle East & Africa CGRP Monoclonal Antibodies Market Size byType (2019-2024) & ($ millions)
Table 39. Middle East & Africa CGRP Monoclonal Antibodies Market Size by Application (2019-2024) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of CGRP Monoclonal Antibodies
Table 41. Key Market Challenges & Risks of CGRP Monoclonal Antibodies
Table 42. Key IndustryTrends of CGRP Monoclonal Antibodies
Table 43. Global CGRP Monoclonal Antibodies Market SizeForecast by Region (2025-2030) & ($ millions)
Table 44. Global CGRP Monoclonal Antibodies Market Size Market ShareForecast by Region (2025-2030)
Table 45. Global CGRP Monoclonal Antibodies Market SizeForecast byType (2025-2030) & ($ millions)
Table 46. Global CGRP Monoclonal Antibodies Market SizeForecast by Application (2025-2030) & ($ millions)
Table 47. Lundbeck Details, CompanyType, CGRP Monoclonal Antibodies Area Served and Its Competitors
Table 48. Lundbeck CGRP Monoclonal Antibodies Product Offered
Table 49. Lundbeck CGRP Monoclonal Antibodies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 50. Lundbeck Main Business
Table 51. Lundbeck Latest Developments
Table 52. AlderTherapeutics Details, CompanyType, CGRP Monoclonal Antibodies Area Served and Its Competitors
Table 53. AlderTherapeutics CGRP Monoclonal Antibodies Product Offered
Table 54. AlderTherapeutics CGRP Monoclonal Antibodies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. AlderTherapeutics Main Business
Table 56. AlderTherapeutics Latest Developments
Table 57.Teva Details, CompanyType, CGRP Monoclonal Antibodies Area Served and Its Competitors
Table 58.Teva CGRP Monoclonal Antibodies Product Offered
Table 59.Teva CGRP Monoclonal Antibodies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60.Teva Main Business
Table 61.Teva Latest Developments
Table 62. Pfizer Inc. Details, CompanyType, CGRP Monoclonal Antibodies Area Served and Its Competitors
Table 63. Pfizer Inc. CGRP Monoclonal Antibodies Product Offered
Table 64. Pfizer Inc. CGRP Monoclonal Antibodies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Pfizer Inc. Main Business
Table 66. Pfizer Inc. Latest Developments
Table 67. Lilly Inc. Details, CompanyType, CGRP Monoclonal Antibodies Area Served and Its Competitors
Table 68. Lilly Inc. CGRP Monoclonal Antibodies Product Offered
Table 69. Lilly Inc. CGRP Monoclonal Antibodies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Lilly Inc. Main Business
Table 71. Lilly Inc. Latest Developments
Table 72. Daiichi Sankyo Co., Ltd. Details, CompanyType, CGRP Monoclonal Antibodies Area Served and Its Competitors
Table 73. Daiichi Sankyo Co., Ltd. CGRP Monoclonal Antibodies Product Offered
Table 74. Daiichi Sankyo Co., Ltd. CGRP Monoclonal Antibodies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Daiichi Sankyo Co., Ltd. Main Business
Table 76. Daiichi Sankyo Co., Ltd. Latest Developments
Table 77. Amgen Inc. Details, CompanyType, CGRP Monoclonal Antibodies Area Served and Its Competitors
Table 78. Amgen Inc. CGRP Monoclonal Antibodies Product Offered
Table 79. Amgen Inc. CGRP Monoclonal Antibodies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Amgen Inc. Main Business
Table 81. Amgen Inc. Latest Developments
Table 82. Novartis International AG Details, CompanyType, CGRP Monoclonal Antibodies Area Served and Its Competitors
Table 83. Novartis International AG CGRP Monoclonal Antibodies Product Offered
Table 84. Novartis International AG CGRP Monoclonal Antibodies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Novartis International AG Main Business
Table 86. Novartis International AG Latest Developments
LIST OFFIGURES
Figure 1. CGRP Monoclonal Antibodies Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global CGRP Monoclonal Antibodies Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. CGRP Monoclonal Antibodies Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. CGRP Monoclonal Antibodies Sales Market Share by Country/Region (2023)
Figure 8. CGRP Monoclonal Antibodies Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global CGRP Monoclonal Antibodies Market Size Market Share byType in 2023
Figure 10. CGRP Monoclonal Antibodies in Hospital
Figure 11. Global CGRP Monoclonal Antibodies Market: Hospital (2019-2024) & ($ millions)
Figure 12. CGRP Monoclonal Antibodies in Specialty Clinic
Figure 13. Global CGRP Monoclonal Antibodies Market: Specialty Clinic (2019-2024) & ($ millions)
Figure 14. CGRP Monoclonal Antibodies in Others
Figure 15. Global CGRP Monoclonal Antibodies Market: Others (2019-2024) & ($ millions)
Figure 16. Global CGRP Monoclonal Antibodies Market Size Market Share by Application in 2023
Figure 17. Global CGRP Monoclonal Antibodies Revenue Market Share by Player in 2023
Figure 18. Global CGRP Monoclonal Antibodies Market Size Market Share by Region (2019-2024)
Figure 19. Americas CGRP Monoclonal Antibodies Market Size 2019-2024 ($ millions)
Figure 20. APAC CGRP Monoclonal Antibodies Market Size 2019-2024 ($ millions)
Figure 21. Europe CGRP Monoclonal Antibodies Market Size 2019-2024 ($ millions)
Figure 22. Middle East & Africa CGRP Monoclonal Antibodies Market Size 2019-2024 ($ millions)
Figure 23. Americas CGRP Monoclonal Antibodies Value Market Share by Country in 2023
Figure 24. United States CGRP Monoclonal Antibodies Market Size Growth 2019-2024 ($ millions)
Figure 25. Canada CGRP Monoclonal Antibodies Market Size Growth 2019-2024 ($ millions)
Figure 26. Mexico CGRP Monoclonal Antibodies Market Size Growth 2019-2024 ($ millions)
Figure 27. Brazil CGRP Monoclonal Antibodies Market Size Growth 2019-2024 ($ millions)
Figure 28. APAC CGRP Monoclonal Antibodies Market Size Market Share by Region in 2023
Figure 29. APAC CGRP Monoclonal Antibodies Market Size Market Share byType (2019-2024)
Figure 30. APAC CGRP Monoclonal Antibodies Market Size Market Share by Application (2019-2024)
Figure 31. China CGRP Monoclonal Antibodies Market Size Growth 2019-2024 ($ millions)
Figure 32. Japan CGRP Monoclonal Antibodies Market Size Growth 2019-2024 ($ millions)
Figure 33. South Korea CGRP Monoclonal Antibodies Market Size Growth 2019-2024 ($ millions)
Figure 34. Southeast Asia CGRP Monoclonal Antibodies Market Size Growth 2019-2024 ($ millions)
Figure 35. India CGRP Monoclonal Antibodies Market Size Growth 2019-2024 ($ millions)
Figure 36. Australia CGRP Monoclonal Antibodies Market Size Growth 2019-2024 ($ millions)
Figure 37. Europe CGRP Monoclonal Antibodies Market Size Market Share by Country in 2023
Figure 38. Europe CGRP Monoclonal Antibodies Market Size Market Share byType (2019-2024)
Figure 39. Europe CGRP Monoclonal Antibodies Market Size Market Share by Application (2019-2024)
Figure 40. Germany CGRP Monoclonal Antibodies Market Size Growth 2019-2024 ($ millions)
Figure 41.France CGRP Monoclonal Antibodies Market Size Growth 2019-2024 ($ millions)
Figure 42. UK CGRP Monoclonal Antibodies Market Size Growth 2019-2024 ($ millions)
Figure 43. Italy CGRP Monoclonal Antibodies Market Size Growth 2019-2024 ($ millions)
Figure 44. Russia CGRP Monoclonal Antibodies Market Size Growth 2019-2024 ($ millions)
Figure 45. Middle East & Africa CGRP Monoclonal Antibodies Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa CGRP Monoclonal Antibodies Market Size Market Share byType (2019-2024)
Figure 47. Middle East & Africa CGRP Monoclonal Antibodies Market Size Market Share by Application (2019-2024)
Figure 48. Egypt CGRP Monoclonal Antibodies Market Size Growth 2019-2024 ($ millions)
Figure 49. South Africa CGRP Monoclonal Antibodies Market Size Growth 2019-2024 ($ millions)
Figure 50. Israel CGRP Monoclonal Antibodies Market Size Growth 2019-2024 ($ millions)
Figure 51.Turkey CGRP Monoclonal Antibodies Market Size Growth 2019-2024 ($ millions)
Figure 52. GCC Countries CGRP Monoclonal Antibodies Market Size Growth 2019-2024 ($ millions)
Figure 53. Americas CGRP Monoclonal Antibodies Market Size 2025-2030 ($ millions)
Figure 54. APAC CGRP Monoclonal Antibodies Market Size 2025-2030 ($ millions)
Figure 55. Europe CGRP Monoclonal Antibodies Market Size 2025-2030 ($ millions)
Figure 56. Middle East & Africa CGRP Monoclonal Antibodies Market Size 2025-2030 ($ millions)
Figure 57. United States CGRP Monoclonal Antibodies Market Size 2025-2030 ($ millions)
Figure 58. Canada CGRP Monoclonal Antibodies Market Size 2025-2030 ($ millions)
Figure 59. Mexico CGRP Monoclonal Antibodies Market Size 2025-2030 ($ millions)
Figure 60. Brazil CGRP Monoclonal Antibodies Market Size 2025-2030 ($ millions)
Figure 61. China CGRP Monoclonal Antibodies Market Size 2025-2030 ($ millions)
Figure 62. Japan CGRP Monoclonal Antibodies Market Size 2025-2030 ($ millions)
Figure 63. Korea CGRP Monoclonal Antibodies Market Size 2025-2030 ($ millions)
Figure 64. Southeast Asia CGRP Monoclonal Antibodies Market Size 2025-2030 ($ millions)
Figure 65. India CGRP Monoclonal Antibodies Market Size 2025-2030 ($ millions)
Figure 66. Australia CGRP Monoclonal Antibodies Market Size 2025-2030 ($ millions)
Figure 67. Germany CGRP Monoclonal Antibodies Market Size 2025-2030 ($ millions)
Figure 68.France CGRP Monoclonal Antibodies Market Size 2025-2030 ($ millions)
Figure 69. UK CGRP Monoclonal Antibodies Market Size 2025-2030 ($ millions)
Figure 70. Italy CGRP Monoclonal Antibodies Market Size 2025-2030 ($ millions)
Figure 71. Russia CGRP Monoclonal Antibodies Market Size 2025-2030 ($ millions)
Figure 72. Egypt CGRP Monoclonal Antibodies Market Size 2025-2030 ($ millions)
Figure 73. South Africa CGRP Monoclonal Antibodies Market Size 2025-2030 ($ millions)
Figure 74. Israel CGRP Monoclonal Antibodies Market Size 2025-2030 ($ millions)
Figure 75.Turkey CGRP Monoclonal Antibodies Market Size 2025-2030 ($ millions)
Figure 76. GCC Countries CGRP Monoclonal Antibodies Market Size 2025-2030 ($ millions)
Figure 77. Global CGRP Monoclonal Antibodies Market Size Market ShareForecast byType (2025-2030)
Figure 78. Global CGRP Monoclonal Antibodies Market Size Market ShareForecast by Application (2025-2030)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global CGRP Monoclonal Antibodies Market Size 2019-2030
2.1.2 CGRP Monoclonal Antibodies Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for CGRP Monoclonal Antibodies by Country/Region, 2019, 2023 & 2030
2.2 CGRP Monoclonal Antibodies Segment by Type
2.2.1 Eptinezumab
2.2.2 Fremanezumab
2.2.3 Galcanezumab
2.2.4 Erenumab
2.3 CGRP Monoclonal Antibodies Market Size by Type
2.3.1 CGRP Monoclonal Antibodies Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global CGRP Monoclonal Antibodies Market Size Market Share by Type (2019-2024)
2.4 CGRP Monoclonal Antibodies Segment by Application
2.4.1 Hospital
2.4.2 Specialty Clinic
2.4.3 Others
2.5 CGRP Monoclonal Antibodies Market Size by Application
2.5.1 CGRP Monoclonal Antibodies Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global CGRP Monoclonal Antibodies Market Size Market Share by Application (2019-2024)
3 CGRP MONOCLONAL ANTIBODIES MARKET SIZE BY PLAYER
3.1 CGRP Monoclonal Antibodies Market Size Market Share by Player
3.1.1 Global CGRP Monoclonal Antibodies Revenue by Player (2019-2024)
3.1.2 Global CGRP Monoclonal Antibodies Revenue Market Share by Player (2019-2024)
3.2 Global CGRP Monoclonal Antibodies Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CGRP MONOCLONAL ANTIBODIES BY REGION
4.1 CGRP Monoclonal Antibodies Market Size by Region (2019-2024)
4.2 Global CGRP Monoclonal Antibodies Annual Revenue by Country/Region (2019-2024)
4.3 Americas CGRP Monoclonal Antibodies Market Size Growth (2019-2024)
4.4 APAC CGRP Monoclonal Antibodies Market Size Growth (2019-2024)
4.5 Europe CGRP Monoclonal Antibodies Market Size Growth (2019-2024)
4.6 Middle East & Africa CGRP Monoclonal Antibodies Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas CGRP Monoclonal Antibodies Market Size by Country (2019-2024)
5.2 Americas CGRP Monoclonal Antibodies Market Size by Type (2019-2024)
5.3 Americas CGRP Monoclonal Antibodies Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC CGRP Monoclonal Antibodies Market Size by Region (2019-2024)
6.2 APAC CGRP Monoclonal Antibodies Market Size by Type (2019-2024)
6.3 APAC CGRP Monoclonal Antibodies Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe CGRP Monoclonal Antibodies Market Size by Country (2019-2024)
7.2 Europe CGRP Monoclonal Antibodies Market Size by Type (2019-2024)
7.3 Europe CGRP Monoclonal Antibodies Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa CGRP Monoclonal Antibodies by Region (2019-2024)
8.2 Middle East & Africa CGRP Monoclonal Antibodies Market Size by Type (2019-2024)
8.3 Middle East & Africa CGRP Monoclonal Antibodies Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CGRP MONOCLONAL ANTIBODIES MARKET FORECAST
10.1 Global CGRP Monoclonal Antibodies Forecast by Region (2025-2030)
10.1.1 Global CGRP Monoclonal Antibodies Forecast by Region (2025-2030)
10.1.2 Americas CGRP Monoclonal Antibodies Forecast
10.1.3 APAC CGRP Monoclonal Antibodies Forecast
10.1.4 Europe CGRP Monoclonal Antibodies Forecast
10.1.5 Middle East & Africa CGRP Monoclonal Antibodies Forecast
10.2 Americas CGRP Monoclonal Antibodies Forecast by Country (2025-2030)
10.2.1 United States Market CGRP Monoclonal Antibodies Forecast
10.2.2 Canada Market CGRP Monoclonal Antibodies Forecast
10.2.3 Mexico Market CGRP Monoclonal Antibodies Forecast
10.2.4 Brazil Market CGRP Monoclonal Antibodies Forecast
10.3 APAC CGRP Monoclonal Antibodies Forecast by Region (2025-2030)
10.3.1 China CGRP Monoclonal Antibodies Market Forecast
10.3.2 Japan Market CGRP Monoclonal Antibodies Forecast
10.3.3 Korea Market CGRP Monoclonal Antibodies Forecast
10.3.4 Southeast Asia Market CGRP Monoclonal Antibodies Forecast
10.3.5 India Market CGRP Monoclonal Antibodies Forecast
10.3.6 Australia Market CGRP Monoclonal Antibodies Forecast
10.4 Europe CGRP Monoclonal Antibodies Forecast by Country (2025-2030)
10.4.1 Germany Market CGRP Monoclonal Antibodies Forecast
10.4.2 France Market CGRP Monoclonal Antibodies Forecast
10.4.3 UK Market CGRP Monoclonal Antibodies Forecast
10.4.4 Italy Market CGRP Monoclonal Antibodies Forecast
10.4.5 Russia Market CGRP Monoclonal Antibodies Forecast
10.5 Middle East & Africa CGRP Monoclonal Antibodies Forecast by Region (2025-2030)
10.5.1 Egypt Market CGRP Monoclonal Antibodies Forecast
10.5.2 South Africa Market CGRP Monoclonal Antibodies Forecast
10.5.3 Israel Market CGRP Monoclonal Antibodies Forecast
10.5.4 Turkey Market CGRP Monoclonal Antibodies Forecast
10.6 Global CGRP Monoclonal Antibodies Forecast by Type (2025-2030)
10.7 Global CGRP Monoclonal Antibodies Forecast by Application (2025-2030)
10.7.1 GCC Countries Market CGRP Monoclonal Antibodies Forecast
11 KEY PLAYERS ANALYSIS
11.1 Lundbeck
11.1.1 Lundbeck Company Information
11.1.2 Lundbeck CGRP Monoclonal Antibodies Product Offered
11.1.3 Lundbeck CGRP Monoclonal Antibodies Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Lundbeck Main Business Overview
11.1.5 Lundbeck Latest Developments
11.2 Alder Therapeutics
11.2.1 Alder Therapeutics Company Information
11.2.2 Alder Therapeutics CGRP Monoclonal Antibodies Product Offered
11.2.3 Alder Therapeutics CGRP Monoclonal Antibodies Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Alder Therapeutics Main Business Overview
11.2.5 Alder Therapeutics Latest Developments
11.3 Teva
11.3.1 Teva Company Information
11.3.2 Teva CGRP Monoclonal Antibodies Product Offered
11.3.3 Teva CGRP Monoclonal Antibodies Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Teva Main Business Overview
11.3.5 Teva Latest Developments
11.4 Pfizer Inc.
11.4.1 Pfizer Inc. Company Information
11.4.2 Pfizer Inc. CGRP Monoclonal Antibodies Product Offered
11.4.3 Pfizer Inc. CGRP Monoclonal Antibodies Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Pfizer Inc. Main Business Overview
11.4.5 Pfizer Inc. Latest Developments
11.5 Lilly Inc.
11.5.1 Lilly Inc. Company Information
11.5.2 Lilly Inc. CGRP Monoclonal Antibodies Product Offered
11.5.3 Lilly Inc. CGRP Monoclonal Antibodies Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Lilly Inc. Main Business Overview
11.5.5 Lilly Inc. Latest Developments
11.6 Daiichi Sankyo Co., Ltd.
11.6.1 Daiichi Sankyo Co., Ltd. Company Information
11.6.2 Daiichi Sankyo Co., Ltd. CGRP Monoclonal Antibodies Product Offered
11.6.3 Daiichi Sankyo Co., Ltd. CGRP Monoclonal Antibodies Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Daiichi Sankyo Co., Ltd. Main Business Overview
11.6.5 Daiichi Sankyo Co., Ltd. Latest Developments
11.7 Amgen Inc.
11.7.1 Amgen Inc. Company Information
11.7.2 Amgen Inc. CGRP Monoclonal Antibodies Product Offered
11.7.3 Amgen Inc. CGRP Monoclonal Antibodies Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Amgen Inc. Main Business Overview
11.7.5 Amgen Inc. Latest Developments
11.8 Novartis International AG
11.8.1 Novartis International AG Company Information
11.8.2 Novartis International AG CGRP Monoclonal Antibodies Product Offered
11.8.3 Novartis International AG CGRP Monoclonal Antibodies Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Novartis International AG Main Business Overview
11.8.5 Novartis International AG Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. CGRP Monoclonal Antibodies Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. CGRP Monoclonal Antibodies Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Eptinezumab
Table 4. Major Players ofFremanezumab
Table 5. Major Players of Galcanezumab
Table 6. Major Players of Erenumab
Table 7. CGRP Monoclonal Antibodies Market Size CAGR byType (2019 VS 2023 VS 2030) & ($ millions)
Table 8. Global CGRP Monoclonal Antibodies Market Size byType (2019-2024) & ($ millions)
Table 9. Global CGRP Monoclonal Antibodies Market Size Market Share byType (2019-2024)
Table 10. CGRP Monoclonal Antibodies Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 11. Global CGRP Monoclonal Antibodies Market Size by Application (2019-2024) & ($ millions)
Table 12. Global CGRP Monoclonal Antibodies Market Size Market Share by Application (2019-2024)
Table 13. Global CGRP Monoclonal Antibodies Revenue by Player (2019-2024) & ($ millions)
Table 14. Global CGRP Monoclonal Antibodies Revenue Market Share by Player (2019-2024)
Table 15. CGRP Monoclonal Antibodies Key Players Head office and Products Offered
Table 16. CGRP Monoclonal Antibodies Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global CGRP Monoclonal Antibodies Market Size by Region (2019-2024) & ($ millions)
Table 20. Global CGRP Monoclonal Antibodies Market Size Market Share by Region (2019-2024)
Table 21. Global CGRP Monoclonal Antibodies Revenue by Country/Region (2019-2024) & ($ millions)
Table 22. Global CGRP Monoclonal Antibodies Revenue Market Share by Country/Region (2019-2024)
Table 23. Americas CGRP Monoclonal Antibodies Market Size by Country (2019-2024) & ($ millions)
Table 24. Americas CGRP Monoclonal Antibodies Market Size Market Share by Country (2019-2024)
Table 25. Americas CGRP Monoclonal Antibodies Market Size byType (2019-2024) & ($ millions)
Table 26. Americas CGRP Monoclonal Antibodies Market Size Market Share byType (2019-2024)
Table 27. Americas CGRP Monoclonal Antibodies Market Size by Application (2019-2024) & ($ millions)
Table 28. Americas CGRP Monoclonal Antibodies Market Size Market Share by Application (2019-2024)
Table 29. APAC CGRP Monoclonal Antibodies Market Size by Region (2019-2024) & ($ millions)
Table 30. APAC CGRP Monoclonal Antibodies Market Size Market Share by Region (2019-2024)
Table 31. APAC CGRP Monoclonal Antibodies Market Size byType (2019-2024) & ($ millions)
Table 32. APAC CGRP Monoclonal Antibodies Market Size by Application (2019-2024) & ($ millions)
Table 33. Europe CGRP Monoclonal Antibodies Market Size by Country (2019-2024) & ($ millions)
Table 34. Europe CGRP Monoclonal Antibodies Market Size Market Share by Country (2019-2024)
Table 35. Europe CGRP Monoclonal Antibodies Market Size byType (2019-2024) & ($ millions)
Table 36. Europe CGRP Monoclonal Antibodies Market Size by Application (2019-2024) & ($ millions)
Table 37. Middle East & Africa CGRP Monoclonal Antibodies Market Size by Region (2019-2024) & ($ millions)
Table 38. Middle East & Africa CGRP Monoclonal Antibodies Market Size byType (2019-2024) & ($ millions)
Table 39. Middle East & Africa CGRP Monoclonal Antibodies Market Size by Application (2019-2024) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of CGRP Monoclonal Antibodies
Table 41. Key Market Challenges & Risks of CGRP Monoclonal Antibodies
Table 42. Key IndustryTrends of CGRP Monoclonal Antibodies
Table 43. Global CGRP Monoclonal Antibodies Market SizeForecast by Region (2025-2030) & ($ millions)
Table 44. Global CGRP Monoclonal Antibodies Market Size Market ShareForecast by Region (2025-2030)
Table 45. Global CGRP Monoclonal Antibodies Market SizeForecast byType (2025-2030) & ($ millions)
Table 46. Global CGRP Monoclonal Antibodies Market SizeForecast by Application (2025-2030) & ($ millions)
Table 47. Lundbeck Details, CompanyType, CGRP Monoclonal Antibodies Area Served and Its Competitors
Table 48. Lundbeck CGRP Monoclonal Antibodies Product Offered
Table 49. Lundbeck CGRP Monoclonal Antibodies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 50. Lundbeck Main Business
Table 51. Lundbeck Latest Developments
Table 52. AlderTherapeutics Details, CompanyType, CGRP Monoclonal Antibodies Area Served and Its Competitors
Table 53. AlderTherapeutics CGRP Monoclonal Antibodies Product Offered
Table 54. AlderTherapeutics CGRP Monoclonal Antibodies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. AlderTherapeutics Main Business
Table 56. AlderTherapeutics Latest Developments
Table 57.Teva Details, CompanyType, CGRP Monoclonal Antibodies Area Served and Its Competitors
Table 58.Teva CGRP Monoclonal Antibodies Product Offered
Table 59.Teva CGRP Monoclonal Antibodies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60.Teva Main Business
Table 61.Teva Latest Developments
Table 62. Pfizer Inc. Details, CompanyType, CGRP Monoclonal Antibodies Area Served and Its Competitors
Table 63. Pfizer Inc. CGRP Monoclonal Antibodies Product Offered
Table 64. Pfizer Inc. CGRP Monoclonal Antibodies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Pfizer Inc. Main Business
Table 66. Pfizer Inc. Latest Developments
Table 67. Lilly Inc. Details, CompanyType, CGRP Monoclonal Antibodies Area Served and Its Competitors
Table 68. Lilly Inc. CGRP Monoclonal Antibodies Product Offered
Table 69. Lilly Inc. CGRP Monoclonal Antibodies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Lilly Inc. Main Business
Table 71. Lilly Inc. Latest Developments
Table 72. Daiichi Sankyo Co., Ltd. Details, CompanyType, CGRP Monoclonal Antibodies Area Served and Its Competitors
Table 73. Daiichi Sankyo Co., Ltd. CGRP Monoclonal Antibodies Product Offered
Table 74. Daiichi Sankyo Co., Ltd. CGRP Monoclonal Antibodies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Daiichi Sankyo Co., Ltd. Main Business
Table 76. Daiichi Sankyo Co., Ltd. Latest Developments
Table 77. Amgen Inc. Details, CompanyType, CGRP Monoclonal Antibodies Area Served and Its Competitors
Table 78. Amgen Inc. CGRP Monoclonal Antibodies Product Offered
Table 79. Amgen Inc. CGRP Monoclonal Antibodies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Amgen Inc. Main Business
Table 81. Amgen Inc. Latest Developments
Table 82. Novartis International AG Details, CompanyType, CGRP Monoclonal Antibodies Area Served and Its Competitors
Table 83. Novartis International AG CGRP Monoclonal Antibodies Product Offered
Table 84. Novartis International AG CGRP Monoclonal Antibodies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Novartis International AG Main Business
Table 86. Novartis International AG Latest Developments
LIST OFFIGURES
Figure 1. CGRP Monoclonal Antibodies Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global CGRP Monoclonal Antibodies Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. CGRP Monoclonal Antibodies Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. CGRP Monoclonal Antibodies Sales Market Share by Country/Region (2023)
Figure 8. CGRP Monoclonal Antibodies Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global CGRP Monoclonal Antibodies Market Size Market Share byType in 2023
Figure 10. CGRP Monoclonal Antibodies in Hospital
Figure 11. Global CGRP Monoclonal Antibodies Market: Hospital (2019-2024) & ($ millions)
Figure 12. CGRP Monoclonal Antibodies in Specialty Clinic
Figure 13. Global CGRP Monoclonal Antibodies Market: Specialty Clinic (2019-2024) & ($ millions)
Figure 14. CGRP Monoclonal Antibodies in Others
Figure 15. Global CGRP Monoclonal Antibodies Market: Others (2019-2024) & ($ millions)
Figure 16. Global CGRP Monoclonal Antibodies Market Size Market Share by Application in 2023
Figure 17. Global CGRP Monoclonal Antibodies Revenue Market Share by Player in 2023
Figure 18. Global CGRP Monoclonal Antibodies Market Size Market Share by Region (2019-2024)
Figure 19. Americas CGRP Monoclonal Antibodies Market Size 2019-2024 ($ millions)
Figure 20. APAC CGRP Monoclonal Antibodies Market Size 2019-2024 ($ millions)
Figure 21. Europe CGRP Monoclonal Antibodies Market Size 2019-2024 ($ millions)
Figure 22. Middle East & Africa CGRP Monoclonal Antibodies Market Size 2019-2024 ($ millions)
Figure 23. Americas CGRP Monoclonal Antibodies Value Market Share by Country in 2023
Figure 24. United States CGRP Monoclonal Antibodies Market Size Growth 2019-2024 ($ millions)
Figure 25. Canada CGRP Monoclonal Antibodies Market Size Growth 2019-2024 ($ millions)
Figure 26. Mexico CGRP Monoclonal Antibodies Market Size Growth 2019-2024 ($ millions)
Figure 27. Brazil CGRP Monoclonal Antibodies Market Size Growth 2019-2024 ($ millions)
Figure 28. APAC CGRP Monoclonal Antibodies Market Size Market Share by Region in 2023
Figure 29. APAC CGRP Monoclonal Antibodies Market Size Market Share byType (2019-2024)
Figure 30. APAC CGRP Monoclonal Antibodies Market Size Market Share by Application (2019-2024)
Figure 31. China CGRP Monoclonal Antibodies Market Size Growth 2019-2024 ($ millions)
Figure 32. Japan CGRP Monoclonal Antibodies Market Size Growth 2019-2024 ($ millions)
Figure 33. South Korea CGRP Monoclonal Antibodies Market Size Growth 2019-2024 ($ millions)
Figure 34. Southeast Asia CGRP Monoclonal Antibodies Market Size Growth 2019-2024 ($ millions)
Figure 35. India CGRP Monoclonal Antibodies Market Size Growth 2019-2024 ($ millions)
Figure 36. Australia CGRP Monoclonal Antibodies Market Size Growth 2019-2024 ($ millions)
Figure 37. Europe CGRP Monoclonal Antibodies Market Size Market Share by Country in 2023
Figure 38. Europe CGRP Monoclonal Antibodies Market Size Market Share byType (2019-2024)
Figure 39. Europe CGRP Monoclonal Antibodies Market Size Market Share by Application (2019-2024)
Figure 40. Germany CGRP Monoclonal Antibodies Market Size Growth 2019-2024 ($ millions)
Figure 41.France CGRP Monoclonal Antibodies Market Size Growth 2019-2024 ($ millions)
Figure 42. UK CGRP Monoclonal Antibodies Market Size Growth 2019-2024 ($ millions)
Figure 43. Italy CGRP Monoclonal Antibodies Market Size Growth 2019-2024 ($ millions)
Figure 44. Russia CGRP Monoclonal Antibodies Market Size Growth 2019-2024 ($ millions)
Figure 45. Middle East & Africa CGRP Monoclonal Antibodies Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa CGRP Monoclonal Antibodies Market Size Market Share byType (2019-2024)
Figure 47. Middle East & Africa CGRP Monoclonal Antibodies Market Size Market Share by Application (2019-2024)
Figure 48. Egypt CGRP Monoclonal Antibodies Market Size Growth 2019-2024 ($ millions)
Figure 49. South Africa CGRP Monoclonal Antibodies Market Size Growth 2019-2024 ($ millions)
Figure 50. Israel CGRP Monoclonal Antibodies Market Size Growth 2019-2024 ($ millions)
Figure 51.Turkey CGRP Monoclonal Antibodies Market Size Growth 2019-2024 ($ millions)
Figure 52. GCC Countries CGRP Monoclonal Antibodies Market Size Growth 2019-2024 ($ millions)
Figure 53. Americas CGRP Monoclonal Antibodies Market Size 2025-2030 ($ millions)
Figure 54. APAC CGRP Monoclonal Antibodies Market Size 2025-2030 ($ millions)
Figure 55. Europe CGRP Monoclonal Antibodies Market Size 2025-2030 ($ millions)
Figure 56. Middle East & Africa CGRP Monoclonal Antibodies Market Size 2025-2030 ($ millions)
Figure 57. United States CGRP Monoclonal Antibodies Market Size 2025-2030 ($ millions)
Figure 58. Canada CGRP Monoclonal Antibodies Market Size 2025-2030 ($ millions)
Figure 59. Mexico CGRP Monoclonal Antibodies Market Size 2025-2030 ($ millions)
Figure 60. Brazil CGRP Monoclonal Antibodies Market Size 2025-2030 ($ millions)
Figure 61. China CGRP Monoclonal Antibodies Market Size 2025-2030 ($ millions)
Figure 62. Japan CGRP Monoclonal Antibodies Market Size 2025-2030 ($ millions)
Figure 63. Korea CGRP Monoclonal Antibodies Market Size 2025-2030 ($ millions)
Figure 64. Southeast Asia CGRP Monoclonal Antibodies Market Size 2025-2030 ($ millions)
Figure 65. India CGRP Monoclonal Antibodies Market Size 2025-2030 ($ millions)
Figure 66. Australia CGRP Monoclonal Antibodies Market Size 2025-2030 ($ millions)
Figure 67. Germany CGRP Monoclonal Antibodies Market Size 2025-2030 ($ millions)
Figure 68.France CGRP Monoclonal Antibodies Market Size 2025-2030 ($ millions)
Figure 69. UK CGRP Monoclonal Antibodies Market Size 2025-2030 ($ millions)
Figure 70. Italy CGRP Monoclonal Antibodies Market Size 2025-2030 ($ millions)
Figure 71. Russia CGRP Monoclonal Antibodies Market Size 2025-2030 ($ millions)
Figure 72. Egypt CGRP Monoclonal Antibodies Market Size 2025-2030 ($ millions)
Figure 73. South Africa CGRP Monoclonal Antibodies Market Size 2025-2030 ($ millions)
Figure 74. Israel CGRP Monoclonal Antibodies Market Size 2025-2030 ($ millions)
Figure 75.Turkey CGRP Monoclonal Antibodies Market Size 2025-2030 ($ millions)
Figure 76. GCC Countries CGRP Monoclonal Antibodies Market Size 2025-2030 ($ millions)
Figure 77. Global CGRP Monoclonal Antibodies Market Size Market ShareForecast byType (2025-2030)
Figure 78. Global CGRP Monoclonal Antibodies Market Size Market ShareForecast by Application (2025-2030)
